Cascade Production of <i>In Situ</i> Oxygen and Singlet Oxygen from Self-Assembled Nanophotosensitizer for Anti-Hypoxic Photodynamic Therapy.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40249842.
- Also identified by DOI 10.1021/acs.nanolett.5c01324.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Photosensitizers (PSs) capable of <i>in situ</i> oxygen (O<sub>2</sub>) production are attractive for overcoming hypoxia in photodynamic therapy (PDT). However, these PSs generally require multiple components and complex fabrication procedures, preventing their clinical translation. Herein, we develop a single-component nanophotosensitizer via simple self-assembly that enables cascade production of <i>in situ</i> O<sub>2</sub> and singlet oxygen (<sup>1</sup>O<sub>2</sub>) for superior antibacterial PDT (aPDT). Perylene tetracarboxylic acid (PTA) molecules self-assemble into nanophotosensitizers (PTA NPs). Mechanism studies reveal dual functionality of PTA NPs due to their antiparallel-displaced π-π stacking. Aggregated PTA molecules undergo intermolecular electron transfer to yield substantial photogenerated holes, while unimolecular PTA undergoes intersystem crossing to produce triplet PS (<sup>3</sup>PS*). These holes effectively oxidize water into O<sub>2</sub> <i>in situ</i>, which then participates in downstream photosensitization with <sup>3</sup>PS* to yield <sup>1</sup>O<sub>2</sub>. This cascade reaction affords PTA NPs with continuous O<sub>2</sub> supply and efficient <sup>1</sup>O<sub>2</sub> production, enabling a 63.07% higher antibacterial rate compared with the clinical antibiotic vancomycin.
Medical subject headings
- Singlet Oxygen
- Photochemotherapy
- Photosensitizing Agents
- Perylene
- Oxygen
- Anti-Bacterial Agents
- Nanoparticles
- Hypoxia